Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979 Sep;8(3):279–281. doi: 10.1111/j.1365-2125.1979.tb01015.x

The effect of chronic oxprenolol therapy on blood prolactin, growth hormone, renin and aldosterone levels.

M J Lewis, A Wilton, G V Groom, A H Henderson
PMCID: PMC1429795  PMID: 497094

Full text

PDF
279

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Groom G. V. The measurement of human gonadotrophins by radioimmunoassay. J Reprod Fertil. 1977 Sep;51(1):273–286. doi: 10.1530/jrf.0.0510273. [DOI] [PubMed] [Google Scholar]
  2. Horrobin D. F., Lloyd I. J., Lipton A., Burstyn P. G., Durkin N., Muiruri K. L. Actions of prolactin on human renal function. Lancet. 1971 Aug 14;2(7720):352–354. doi: 10.1016/s0140-6736(71)90065-1. [DOI] [PubMed] [Google Scholar]
  3. Horrobin D. F., Manku M. S., Burstyn P. G. Effect of intravenous prolactin infusion on arterial blood pressure in rabbits. Cardiovasc Res. 1973 Sep;7(5):585–587. doi: 10.1093/cvr/7.5.585. [DOI] [PubMed] [Google Scholar]
  4. Lacey J. H., Crisp A. H., Groom G. V., Seldrup J. The impact of clomipramine and its withdrawal on some nocturnal hormone profiles--a preliminary report. Postgrad Med J. 1977;53 (Suppl 4):182–189. [PubMed] [Google Scholar]
  5. Lewis M. J. Effect of acute and chronic treatment with practolol on cardiovascular responses in the pithed rat. J Pharm Pharmacol. 1974 Oct;26(10):783–788. doi: 10.1111/j.2042-7158.1974.tb09174.x. [DOI] [PubMed] [Google Scholar]
  6. Morinan A., Leonard B. E. Effects of chronic (+/-)-propranolol on catecholamines and GABA in rat striatum [proceedings]. Br J Pharmacol. 1977 Sep;61(1):152P–152P. [PMC free article] [PubMed] [Google Scholar]
  7. Nasrallah H. A., Freed W. J., Rogol A., Wyatt R. J. Propranolol and prolactin. Lancet. 1977 Dec 3;2(8049):1175–1176. doi: 10.1016/s0140-6736(77)91563-x. [DOI] [PubMed] [Google Scholar]
  8. Oparil S., Koerner T. J., Haber E. Effects of pH and enzyme inhibitors on apparent generation of angiotensin I in human plasma. J Clin Endocrinol Metab. 1974 Nov;39(5):965–968. doi: 10.1210/jcem-39-5-965. [DOI] [PubMed] [Google Scholar]
  9. Raine A. E., Chubb I. W. Long term beta-adrenergic blockade reduces tyrosine hydroxylase and dopamine beta-hydroxylase activities in sympathetic ganglia. Nature. 1977 May 19;267(5608):265–267. doi: 10.1038/267265a0. [DOI] [PubMed] [Google Scholar]
  10. Stokes G. S., Weber M. A., Thornell I. R. Beta-blockers and plasma renin activity in hypertension. Br Med J. 1974 Jan 12;1(5897):60–62. doi: 10.1136/bmj.1.5897.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stumpe K. O., Kolloch R., Higuchi M., Krück F., Vetter H. Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control. Lancet. 1977 Jul 30;2(8031):211–214. doi: 10.1016/s0140-6736(77)92832-x. [DOI] [PubMed] [Google Scholar]
  12. Waite M. A. Measurement of concentrations of angiotensin I in human blood by radioimmunoassay. Clin Sci. 1973 Jul;45(1):51–64. doi: 10.1042/cs0450051. [DOI] [PubMed] [Google Scholar]
  13. Wilton A. Plasma renin activity and angiotensin II concentrations in sarcoidosis. Br Med J. 1977 Nov 12;2(6097):1262–1263. doi: 10.1136/bmj.2.6097.1262-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES